2012;6:CD000253
Testing reveals your individual peptide-pathway profile across 49 peptides and 14 pathways, helping you optimize your treatment plan
National Research Council (NRC)
Lenny Macrina: Right, and they talk about swelling, joint pain, anxiety, panic attacks, heart palpitations, insomnia, drowsiness, weakness, fatigue, loss of appetite, depression, anhedonia
Reduction of sun damage, acne scars, and related skin issues
MRTX1719 is an MTA-Cooperative PRMT5 inhibitor that exhibits synthetic lethality in preclinical models and patients with MTAPDeleted cancer